In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris

Phytomedicine

Volumn 16, Issue 4, 2009, Pages 369-376

  Yamaguchi, Naoto ^a   Satoh Yamaguchi, Keiko ^a   Ono, Mitsunori ^a  

^a Betal LLC   (United States)

Author keywords

Acne causing bacteria; Humulus lupulus; Matrix metalloproteinases; Oxygen radical absorbance; Singlet oxygen absorbance; Xanthohumol

Indexed keywords

HUMULON; LUPULON; OXYGEN; REACTIVE OXYGEN METABOLITE; XANTHOHUMOL;

ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; ANTICOLLAGENASE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; DRUG ACTIVITY; DRUG STRUCTURE; EVALUATION; HUMULUS LUPULUS; HYDROGENATION; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES;

ACNE VULGARIS; ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; BACTERIA; BIPHENYL COMPOUNDS; COLLAGENASES; CYCLOHEXENES; HUMANS; HUMULUS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 8; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PICRATES; PLANT EXTRACTS; PROPIONIBACTERIUM ACNES; PROPIOPHENONES; STAPHYLOCOCCUS; TERPENES;

HUMULUS LUPULUS; KOCURIA RHIZOPHILA; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES;

EID: 62549158632     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.12.021     Document Type: Article

References (48)

1. Altindag O., Erel O., Aksoy N., Selek S., Celik H., and Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol. Int. 27 (2007) 339-344
2. Arakane K., Ryu A., Hayashi C., Masunaga T., Shinmoto K., Mashiko S., Nagano T., and Hirobe M. Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. Biochem. Biophys. Res. Commun. 223 (1996) 578-582
3. Ashkenazi H., Malik Z., Harth Y., and Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol. Med. Microbiol. 35 (2003) 17-24
4. Aubry J.M., Cazin B., and Duprat J. Chemical sources of singlet oxygen 3. Peroxidation of water-soluble singlet oxygen carriers with the hydrogen peroxide-molybdate system. J. Org. Chem. 54 (1989) 726-728
5. Auffray B. Protection against singlet oxygen the main actor of sebum squalene peroxidation during sun exposure, using Commiphora myrrha essential oil. Int. J. Cosmet. Sci. 29 (2007) 23-29
6. Bickers D.R., and Athar M. Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 126 (2006) 2565-2575
7. Brenneisen P., Sies H., and Scharffetter-Kochanek K. Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. NY Acad. Sci. 973 (2002) 31-43
8. Buchan P. Evaluation of the teratogenic risk of cutaneously administered retinoids. Skin Pharmacol. 6 (1993) 45-52
9. Cho Y.C., Kim H.J., Kim Y.J., Lee K.Y., Choi H.J., Lee I.S., and Kang B.Y. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int. Immunopharmacol. 8 (2008) 567-573
10. Choi J.Y., Piao M.S., Lee J.B., Oh J.S., Kim I.G., and Lee S.C. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts. J. Invest. Dermatol. 128 (2008) 846-854
11. Cohlan S.Q. Congenital anomalies in the rat produced by excessive intake of vitamin A during pregnancy. Pediatrics 13 (1954) 556-567
12. Cookson J.S., and Lawton A. Hop dermatitis in Herefordshire. Br. Med. J. 2 (1953) 376-379
13. Del Rosso J.Q. Newer topical therapies for the treatment of acne vulgaris. Cutis 80 (2007) 400-410
14. Espersen F. Resistance to antibiotics used in dermatological practice. Br. J. Dermatol. Suppl. 53 (1998) 4-8
15. Gerhauser C. Broad spectrum and anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol. Nutr. Food Res. 49 (2005) 827-831
16. Gollnick H., and Schramm M. Topical drug treatment in acne. Dermatology 196 (1998) 119-125
17. Haas G.J., and Barsoumian R. Antimicrobial activity of hop resins 57 (1994) 59-61
18. Hougee S., Faber J., Sanders A., Berg W.B., Garssen J., Smit H.F., and Hoijer M.A. Selective inhibition of COX-2 by a standardized CO2 extract of Humulus lupulus in vitro and its activity in a mouse model of zymosan-induced arthritis. Planta Med. 72 (2006) 228-233
19. Knight C.G., Willenbrock F., and Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296 (1992) 263-266
20. Kang S., Cho S., Chung J.H., Hammerberg C., Fisher G.J., and Voorhees J.J. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am. J. Pathol. 166 (2005) 1691-1699
21. Kennedy S.H., Manevich Y., and Biaglow J. Benzoyl peroxide acts as a promoter of radiation induced malignant transformation in vitro. Biochem. Biophys. Res. Commun. 212 (1995) 1118-1125
22. Kraus A.L., Munro I.C., Orr J.C., Binder R., LeBoeuf R.A., and Williams G.M. Benzoyl peroxide: an integrated human safety assessment for carcinogenicity. Regul. Toxicol. Pharmacol. 21 (1995) 87-107
23. Lee J.C., Kundu J.K., Hwang D.M., Na H.K., and Surh Y.J. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Carcinogenesis 28 (2007) 1491-1498
24. Moan J., and Juzenas P. Singlet oxygen in photosensitization. J. Environ. Pathol. Toxicol. Oncol. 25 (2006) 29-50
25. Monteiro R., Calhau C., Silva A.O., Pinheiro-Silva S., Guerreiro S., Gärtner F., Azevedo I., and Soares R. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J. Cell Biochem. 104 (2008) 1699-1707
26. Okada Y., and Okada M. Scavenging effect of water soluble proteins in broad beans on free radicals and active oxygen species. J. Agric. Food Chem. 46 (1998) 401-406
27. Olson M.W., Gervasi D.C., Mobashery S., and Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase TIMP-1 and TIMP-2. J. Biol. Chem. 272 (1997) 29975-29983
28. Ou B., Hampsch-Woodill M., and Prior R.L. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem. 49 (2001) 4619-4626
29. Ou B., Hampsch-Woodill M., Flanagan J.A., Deemer E.K., Prior R.L., and Huang D. Novel fluorometric assay for hydroxyl radical prevention capacity using fluorescein as the probe. J. Agric. Food Chem. 50 (2002) 2772-2777
30. Ou B., Hampsch-Woodill M., Flanagan J.A., and Deemer E.K. Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: a comparative study. J. Agric. Food Chem. 50 (2002) 3122-3128
31. FL) of plasma and other biological and food samples. J. Agric. Food Chem. 51 (2003) 3273-3279
32. Rahimi R., Nikfar S., Larijani B., and Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother. 59 (2005) 365-373
33. Raith L., and Jäger K. Hop allergy. Contact Dermatitis 11 (1984) 53
34. Rao A.V., and Rao L.G. Carotenoids and human health. Pharmacol. Res. 55 (2007) 207-216
35. Schmalreck A.F., Teuber M., Reininger W., and Hartl A. Structural features determining the antibiotic potencies of natural and synthetic hop bitter resins, their precursors and derivatives. Can. J. Microbiol. 21 (1975) 205-212
36. Shi Q., and Gibson G.E. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 21 (2007) 276-291
37. Sies H., and Krinsky N.I. The present status of antioxidant vitamins and beta-carotene. Am. J. Clin. Nutr. 62 (1995) 12995-13005
38. Spiewak R., and Dutkiewicz J. Occupational airborne and hand dermatitis to hop (Humulus lupulus) with non-occupational relapses. Ann. Agric. Environ. Med. 9 (2002) 249-252
39. Suzuki K., Iijima K., Sakamoto K., Sami M., and Yamashita H. A review of hop resistance in beer spoilage lactic acid bacteria. J. Inst. Brew. 112 (2006) 173-191
40. Tagashira M., Watanabe M., and Uemitsu N. Antioxidative activity of hop bitter acids and their analogues. Biosci. Biotechnol. Biochem. 59 (1995) 740-742
41. Tripp, M.L., Babish, J.G., Bland, J.S., Darland, G.K., Lerman, R., Lukaczer, D.O., Liska, D.J., Howell, T., 2007. Compositions that treat or inhibit pathological conditions associated with inflammatory response. US Patent: 7,270,835.
42. Viyoch J., Pisutthanan N., Falikreua A., Nupangta K., Wangtorpol K., and Nagokkuen J. Evaluation of in vitro antimicrobial activity of Thai basil oils and their micro-emulsion formulas against Propionibacterium acnes. Int. J. Cosmet. Sci. 28 (2006) 125-133
43. Vogel S., Ohmayer S., Brunner G., and Heilmann J. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem. 16 (2008) 4286-4293
44. Yamaguchi, N., Ono, M., 2007a. Method for preparing stable hop powder. US Patent Application: 11/868,226.
45. Yamaguchi, N., Ono, M., 2007b. Xanthohumol-enriched hop extract. US Patent Application: 60/955,906.
46. Yamaguchi, N., Ono, M., 2008. Method for preparing alpha acid-enriched hop composition. US Patent Application: 61/054,354.
47. Zanoli P., and Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J. Ethnopharmacol. 116 (2008) 383-396
48. Zhao F., Nozawa H., Daikonnya A., Kondo K., and Kitanaka S. Inhibition of nitric oxide production from hops (Humulus lupulus L.). Biol. Pharm. Bull. 26 (2003) 61-65